Guobang Pharma Ltd (605507) — Cash Flow Quality Index
Guobang Pharma Ltd (605507) has a Cash Flow Quality Index of 1.45x as of September 2025. Operating cash flow of CN¥311.27 Million exceeds net income of CN¥214.67 Million, indicating high earnings quality where cash backs reported profits. Also explore Guobang Pharma Ltd asset portfolio for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Guobang Pharma Ltd Cash Flow Quality Index (2017–2025)
Historical Cash Flow Quality Index for Guobang Pharma Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 605507 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Guobang Pharma Ltd (2017–2025)
Year-by-year earnings quality comparison for Guobang Pharma Ltd. For live market cap and the full company financial profile, see Guobang Pharma Ltd (605507) market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.68x | CN¥559.28 Million | CN¥820.82 Million | ▼ -24.7% |
| 2024 | 0.90x | CN¥706.41 Million | CN¥780.58 Million | ▲ +7.3% |
| 2023 | 0.84x | CN¥516.76 Million | CN¥612.46 Million | ▼ -23.6% |
| 2022 | 1.10x | CN¥1.02 Billion | CN¥920.62 Million | ▲ +542.8% |
| 2021 | -0.25x | CN¥-176.18 Million | CN¥706.23 Million | ▼ -126.3% |
| 2020 | 0.95x | CN¥767.70 Million | CN¥810.29 Million | ▲ +6.2% |
| 2019 | 0.89x | CN¥440.86 Million | CN¥494.01 Million | ▼ -20.4% |
| 2018 | 1.12x | CN¥541.68 Million | CN¥483.46 Million | ▲ +196.1% |
| 2017 | 0.38x | CN¥148.03 Million | CN¥391.25 Million | — |